Finance

Lists
600285:SHA
Henan Lingrui Pharmaceutical Co., Ltd.
CNÂ¥20.08
+0.96%
(+0.19) 1D
Aug 28, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600285...
Open
CNÂ¥19.90
High
CNÂ¥20.17
Low
CNÂ¥19.80
Mkt. cap
11.28B
Avg. vol.
12.79M
Volume
7.19M
Dividend
5.48%
Quarterly dividend
CNÂ¥0.28
Ex-dividend date
Jun 11, 2026
P/E ratio
14.60
52-wk high
CNÂ¥23.65
52-wk low
CNÂ¥19.00
EPS
CNÂ¥1.38
Shares outstanding
586.45M
No. of employees
3K
Open
CNÂ¥19.90
High
CNÂ¥20.17
Low
CNÂ¥19.80
Mkt. cap
11.28B
Avg. vol.
12.79M
Volume
7.19M
Dividend
5.48%
Quarterly dividend
CNÂ¥0.28
Ex-dividend date
Jun 11, 2026
P/E ratio
14.60
52-wk high
CNÂ¥23.65
52-wk low
CNÂ¥19.00
EPS
CNÂ¥1.38
Shares outstanding
586.45M
No. of employees
3K
About Henan Lingrui Pharmaceutical Co., Ltd.
CEO-
Employees2.79K
Founded1992
Headquarters-
SectorPharmaceutical industry
Websitelingrui.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
942.16M
812.03M
1.13B
1.02B
Cost of goods sold
184.05M
194.87M
245.62M
207.96M
Cost of revenue
184.05M
194.87M
245.62M
207.96M
Research and development expenses
41.54M
64.52M
31.48M
21.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
514.55M
427.97M
563.59M
499.32M
Operating expense
561.41M
503.84M
613.11M
537.69M
Total operating expenses
745.46M
698.71M
858.73M
745.65M
Operating income
196.69M
113.32M
267.34M
276.25M
Other non operating income
1.01M
-1.78M
-111.14K
-323.41K
EBT including unusual items
206.01M
121.91M
285.51M
291.80M
EBT excluding unusual items
211.20M
125.02M
284.47M
287.74M
Income tax expense
28.34M
13.00M
38.07M
41.39M
Effective tax rate
13.76%
10.66%
13.33%
14.18%
Other operating expenses
1.14M
17.18M
9.49M
14.23M
Net income
176.55M
108.57M
246.33M
248.76M
Net profit margin
18.74%
13.37%
21.88%
24.34%
Earnings per share
-
-
-
-
Interest and investment income
15.15M
14.40M
18.00M
12.30M
Interest expense
-1.66M
-908.91K
-763.97K
-499.14K
Net interest expenses
13.48M
13.50M
17.24M
11.81M
Depreciation and amortization charges
-
-
-
-
EBITDA
214.63M
137.12M
291.15M
299.03M
Gain or loss from assets sale
4.70M
-6.99M
-
15.10K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps